ArticleScientific reports2025
Effects of rs3802177 G/A polymorphism on SLC30A8 mRNA and hsa-miR-183-5p in Malay women with gestational diabetes mellitus.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Gestational diabetes mellitus (GDM) is characterized by the initial presentation of impaired glucose tolerance identified during pregnancy. Numerous investigations have explored the associations between single nucleotide polymorphisms (SNPs) and microRNAs in relation to the susceptibility to GDM across diverse populations. This study aimed to investigate the interplay among rs3802177 G/A 3' UTR polymorphism, SLC30A8 mRNA expression, and hsa-miR-183-5p in Malay women with GDM. TargetScanHuman, miRBase, miRRecord, and Sfold bioinformatics tools were applied to predict and select a putative microRNA that has a significant interaction with SLC30A8 mRNA at the 3' UTR region. DNA was extracted and genotyped using the Sequenom Mass ARRAY method. Quantitative PCR was performed to evaluate SLC30A8 mRNA and hsa-miR-183-5p expression levels. Preliminary bioinformatics analysis revealed that hsa-miR-183-5p is a potential target for SLC30A8. Thermodynamic evaluation confirmed a negative association between polymorphisms and SLC30A8 mRNA secondary structure (P = 0.8027). Data analysis showed that the GG genotype in patients with GDM is a risk allele for GDM in the Malay population. Furthermore, the SLC30A8 gene was significantly downregulated (P < 0.05), whereas miR-183-5P was significantly upregulated (P < 0.05) in patients with the GG genotype. In addition, the ROC curve analysis revealed that hsa-miR-183-5p has potential as a biomarker (AUC = 0.7926 ± 0.02045, p = 0.0001) in the first trimester of GDM. In conclusion, this study provides the first evidence of a substantial association in the interplay among the rs3802177 G/A SNP, SLC30A8 mRNA expression, and hsa-miR-183-5p expression levels in the Malay population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.